Ashraf Amanullah
Chief Tech/Sci/R&D Officer at INHIBRX, INC.
Profile
Ashraf Amanullah is currently the Chief Technical Operations Officer & Executive VP at Inhibrx, Inc. Prior to this, he held positions as the Director-Process Development at Genentech, Inc. from 2006 to 2011, Senior Director at Gilead Sciences, Inc. from 2011 to 2015, and Senior VP-Biologics Development & Manufacturing at aTyr Pharma, Inc. in 2018.
He obtained his undergraduate degree from the University of Birmingham and his doctorate degree from The University of Sheffield.
Ashraf Amanullah active positions
| Companies | Position | Start |
|---|---|---|
| INHIBRX, INC. | Chief Tech/Sci/R&D Officer | 2018-07-31 |
Former positions of Ashraf Amanullah
| Companies | Position | End |
|---|---|---|
| ATYR PHARMA, INC. | Corporate Officer/Principal | 2018-06-30 |
| GILEAD SCIENCES, INC. | Director/Board Member | 2015-07-31 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 2011-07-31 |
Training of Ashraf Amanullah
| University of Birmingham | Undergraduate Degree |
| The University of Sheffield | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| ATYR PHARMA, INC. | Health Technology |
| INHIBRX, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Ashraf Amanullah
